%20and%20Batch%20Production%20Records%20(BPR).png)
Lupin receives US FDA approval for Dapagliflozin tablets
Lupin announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Dapagliflozin tablets, 5 mg and 10 mg.
The U.S. FDA has approved Lupin’s Dapagliflozin tablets, 5 mg and 10 mg, as bioequivalent to Farxiga for the indications in the approved labelling.
The post Lupin receives US FDA approval for Dapagliflozin tablets appeared first on Express Pharma.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
Edusehat
Platform Edukasi Online Untuk Komunitas Kesehatan Agar Mendapatkan Informasi Dan Pengetahuan Terbaru Tentang Kesehatan Dari Nasional Maupun Internasional. ||
An online education platform for the health community to obtain the latest information and knowledge about health from both national and international sources.
